IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v48y2025i5d10.1007_s40264-025-01514-z.html
   My bibliography  Save this article

Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature

Author

Listed:
  • Harjit Singh

    (Medstar Georgetown University Hospital)

  • Bryce F. Kunkle

    (Medstar Georgetown University Hospital)

  • Angela R. Troia

    (Medstar Georgetown University Hospital)

  • Advait M. Suvarnakar

    (Georgetown University School of Medicine)

  • Ade C. Waterman

    (Medstar Georgetown University Hospital)

  • Yadana Khin

    (Medstar Georgetown University Hospital)

  • Serena Y. Korkmaz

    (Medstar Georgetown University Hospital)

  • Corinne E. O’Connor

    (Medstar Georgetown University Hospital)

  • James H. Lewis

    (Medstar Georgetown University Hospital)

Abstract

Drug-induced liver injury (DILI) remains an active field of clinical research and investigation with more than 4700 publications appearing in 2023 relating to hepatotoxicity of all causes and injury patterns. As in years past, we have attempted to identify and summarize highlights and controversies from the past year’s literature. Several new and novel therapeutic agents were approved by the US Food and Drug Administration (FDA) in 2023, a number of which were associated with significant hepatotoxicity. Updates in the diagnosis and management of DILI using causality scores as well as newer artificial intelligence-based methods were published. Details of newly established hepatotoxins as well as updated information on previously documented hepatotoxic drugs is presented. Significant updates in treatment of DILI were also included as well as reports related to global DILI registries.

Suggested Citation

  • Harjit Singh & Bryce F. Kunkle & Angela R. Troia & Advait M. Suvarnakar & Ade C. Waterman & Yadana Khin & Serena Y. Korkmaz & Corinne E. O’Connor & James H. Lewis, 2025. "Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature," Drug Safety, Springer, vol. 48(5), pages 455-488, May.
    • Handle: RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-025-01514-z
    DOI: 10.1007/s40264-025-01514-z
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-025-01514-z
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-025-01514-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-025-01514-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.